The National Polio Oral Vaccination Campaign kicked off March 14 in the country benefitting over 26 thousand children in the western province of Matanzas.

After six weeks of decrease, Cuba presented an increase in the number of autochthonous cases of COVID-19, informed today Francisco Duran, national director of epidemiology of the ministry of public health.

Cuba studied a total of 10,654 samples to detect cases of COVID 19 during the day, resulting positive 620 for 5.8% positivity. The country accumulates 13, 241,152 samples taken and 1,077,405 positive (8.1%).

The 61st edition of the National Oral Polio Vaccination Campaign will begin this Monday throughout the country, in which all children from one month old to two years, 11 months and 29 days of age will be immunized in two phases.

Cuban Health Ministry reported the administration so far of 35 million 113 thousand 686 doses of the locally developed COVID-19 vaccines Soberana 02, Soberana Plus and Abdala.

 Cuban public health ministry (MINSAP its Spanish acronym) announced today that the 61st National Oral Polio Vaccination Campaign will begin next Monday, March 14, in the country.

Cuba studied a total of 11,326 samples for surveillance during the day, with 586 positive for 5.2% positivity. The country accumulates 13, 207,204 samples taken and 1,075,616 positive (8.1%).

Cuba reported no deaths from COVID-19 on Wednesday, when 561 new coronavirus cases were detected by lab tests.

Nine Million 890 thousand 964 people in Cuba have already completed their COVID-19 immunization with the homegrown vaccines Soberana 02, Soberana Plus and Abdala; the figure stands for 89.3 percent of the Cuban population.

Cuba continues to report about 500 COVID-19 daily cases. Health Authorities said 518 cases were detected on Tuesday, 575 patients recovered and one person died from the disease.

The Havana-based Molecular Immunology Center announced the approval by the local drugs regulatory authority of the product known as NeuroEpo, to treat patients suffering from moderate and slight Alzheimer disease.

Cuba studied a total of 7,869 samples for surveillance during the day, 447 of which were positive. The country accumulates 13, 173,948 samples taken and 1,073,951 positive.

A total of 9,888,617 people in Cuba have already completed the vaccination scheme against COVID-19, with the immunogens developed in the country Soberana 02, Soberana Plus and Abdala.

 Across the planet, the first year of the SARS-CoV-2 pandemic triggered a 25% increase in the prevalence of anxiety and depression.